Tango Therapeutics

Business Services · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

201 Brookline Ave Ste 901, Boston, Massa...

Phone Number

(857) 320-4900

Revenue

$57 Million

Stock Symbol

TNGX

Industry

Business Services Research & Development

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company focused on discovering and developing precision oncology therapies. The company leverages genetic insights and targeted drug discovery to develop novel cancer treatments for genetically defined patient populations with significant unmet medical needs.Explore more
Tango Therapeutics's Social MediaSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: TNGXShow more

Tango Therapeutics Org Chart

PhoneEmail
Matthew Gall, Chief Financial Officer at Tango Therapeutics
United States flag for contact location.

Chief Financial Officer

PhoneEmail
JC
United States flag for contact location.

Chief Human Resources Officer

PhoneEmail
AC
United States flag for contact location.

President, Research & Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
EP
United States flag for contact location.

Vice President, Investor Relations & Corporat...

PhoneEmail
EH
United States flag for contact location.

Vice President, Investor Relations & Corporat...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Tango Therapeutics

Compare insights from companies similar to Tango Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Tango Therapeutics

$57M
51-200
Public
$455M
2017
Matthew Gall, Chief Financial Officer at Tango Therapeutics
Matthew GallChief Financial Officer
$15M
51-200
Private
$181.5M
2015
$8.7M
11-50
Private
-
2009
DS
David ShanahanCEO & Chairman
$7.6M
11-50
Private
-
2019
EN
Elizabeth NicholsManager, Investor Relations
$7.1M
51-200
Public
$398M
2018
51-200
Public
$198M
2019
Jennifer Bush, Chief Operating Officer at Artiva
Jennifer BushChief Operating Officer
Illustration of an envelope

Tango Therapeutics Tech Stack

A closer look at the technologies used by Tango Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Tango Therapeutics

What is Tango Therapeutics's stock symbol?
Tango Therapeutics's stock symbol is TNGX
What is Tango Therapeutics's official website?
Tango Therapeutics's official website is www.tangotx.com
What is Tango Therapeutics's Revenue?
Tango Therapeutics's revenue is $57 Million
What is Tango Therapeutics's SIC code?
Tango Therapeutics's SIC: 87,873
What is Tango Therapeutics's NAICS code?
Tango Therapeutics's NAICS: 54,541
How many employees does Tango Therapeutics have?
Tango Therapeutics has 51-200 employees
What industry does Tango Therapeutics belong to?
Tango Therapeutics is in the industry of: Business Services, Research & Development
What is Tango Therapeutics competition?
Tango Therapeutics top competitors include: Tscan Therapeutics, Gradalis, Century Therapeutics, Artiva
What technology does Tango Therapeutics use?
Some of the popular technologies that Tango Therapeutics uses are: DocuSign, WordPress.org, PHP, Microsoft SharePoint
Who is the CFO of Tango Therapeutics?
Tango Therapeutics's CFO is Matthew Gall
How do I contact Tango Therapeutics?
Tango Therapeutics contact info: Phone number: (857) 320-4900 Website: www.tangotx.com
What does Tango Therapeutics do?

Tango Therapeutics is a clinical-stage biotechnology company focused on discovering and developing precision oncology therapies. The company leverages genetic insights and targeted drug discovery to develop novel cancer treatments for genetically defined patient populations with significant unmet medical needs.... Read More

What are Tango Therapeutics social media links?
Tango Therapeutics Linkedin page Tango Therapeutics Twitter page
Who invested in Tango Therapeutics?
Tango Therapeutics has 9 investors including Farallon, Casdin Capital , LLC, Boxer Capital , LLC, Cormorant Asset Management and LLC.
Is Tango Therapeutics a public company?
Yes, Tango Therapeutics is a public company and is traded under the symbol TNGX
See more information about Tango Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.